Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02160210
Other study ID # E-001
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 9, 2014
Last updated June 9, 2014
Start date June 2014
Est. completion date August 2014

Study information

Verified date June 2014
Source First Affiliated Hospital of Harbin Medical University
Contact n/a
Is FDA regulated No
Health authority China: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This study is the evaluation of ultrafine endoscope (with small caliber and turning radius )for colonoscopy in decreasing abdominal pain of patients . 60 patients will be accepted in this trial.


Description:

The aim of this study is to investigate the advantages of an endoscope with smaller turning radius and softer insert section in reducing patients' abdominal pain in colonoscopy. Transnasal gastroscope was selected in this study , because of its small caliber (5.9mm) and small turning radius . Visual analogue scale(VAS),cecum intubation time and cecum intubation rate were evaluated.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date August 2014
Est. primary completion date August 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Patients diagnostic colonoscopy;

2. Subjects able to provide informed consent

Exclusion Criteria:

1. Patients with poor bowel preparation;

2. Contraindications of the colonoscopy;

3. Prior partial or complete colectomy

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic


Intervention

Device:
Ultrafine Endoscope
Ultrafine endoscope reaching to the cecum within 15mins is thought to be successful.Water colonoscopy with standard colonoscope will be performed in unsuccessful subjects subsequently.

Locations

Country Name City State
China The Gastroenterology Department of The 1st Affiliated Hospital of Harbin Medical University Harbin Heilongjiang

Sponsors (1)

Lead Sponsor Collaborator
Youlin Yang ,MD

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary VAS abdominal pain scores VAS abdominal pain scores include pain scores in the insertion phase of splenic flexure,hepatic flexure,and ileocecal junction.(0=no pain and 10=most severe pain imaginable). up to two months No
Secondary Cecum intubation time Insertion time from rectum to reach the cecum. up to two months No
Secondary The time to reach the splenic flexure Insertion time from rectum to reach the flexure. up to two months No
Secondary The time to reach the hepatic flexure Insertion time from rectum to hepatic flexure. up to two months No
Secondary The success rate of the cecal intubation within 15 minutes Percentage of successful colonoscopy (insertion of ultrafine endoscope into cecum within 15 minutes). up to two months No
See also
  Status Clinical Trial Phase
Completed NCT02662946 - Evaluation of Intestinal Vascolarization With Indocianine Green Angiography During Rectal Resection or Left Colectomy N/A
Recruiting NCT01762735 - Water Injection Colonoscopy vs Air Insufflation Colonoscopy in Training the Beginners N/A
Recruiting NCT01797393 - "Air Assisted"Water Injection Colonoscopy in Experienced Endoscopists N/A